A phase I and pharmacokinetic trial of erlotinib in combination with weekly docetaxel in patients with taxane-naive malignancies.

A phase I and pharmacokinetic trial of erlotinib in combination with weekly docetaxel in patients with taxane-naive malignancies.

Item
http://www.wikidata.org/entity/Q46748252
EGFR Targeting in Hormone-Refractory Prostate Cancer: Current Appraisal and Prospects for Treatment.Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: case report and review of the literature.Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN).Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations.Level of evidence for therapeutic drug monitoring of taxanes.Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on 4-anilinoquinazolines.Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targets.Clinical aspects and perspectives of erlotinib in the treatment of patients with biliary tract cancer.A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study.
P2860

A phase I and pharmacokinetic trial of erlotinib in combination with weekly docetaxel in patients with taxane-naive malignancies.

Item
http://www.wikidata.org/entity/Q46748252
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
A phase I and pharmacokinetic ...... ith taxane-naive malignancies.
@en
A phase I and pharmacokinetic ...... ith taxane-naive malignancies.
@nl
type
label
A phase I and pharmacokinetic ...... ith taxane-naive malignancies.
@en
A phase I and pharmacokinetic ...... ith taxane-naive malignancies.
@nl
prefLabel
A phase I and pharmacokinetic ...... ith taxane-naive malignancies.
@en
A phase I and pharmacokinetic ...... ith taxane-naive malignancies.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
A phase I and pharmacokinetic ...... with taxane-naive malignancies
@en
P2093
P304
P31
P356
10.1158/1078-0432.CCR-07-0437
P407
P433
P478
P50
P577
P698
P921